Griep

Paulus Antonius Maria Griep, Heeze NL

Patent application number	Description	Published
20090124870	PATIENT MONITORING SYSTEM FOR THE REAL-TIME DETECTION OF EPILEPTIC SEIZURES - A patient monitoring system for the real-time detection of epileptic seizures suffered by a user of the monitoring system. The system comprises control means for receiving measuring signals and, conditional upon the measuring signals, generating an alarm signal, at least one hart rate sensor for measuring the heart rate of the user and, subject to the measurement, generating a heart rate signal, and at least one muscular tension sensor for measuring the change and the intensity of the contraction of at least one muscle of the user and, subject to the measurement, generating a muscle contraction signal. The control means are designed for, subject to both the heart signal and the muscle contraction signal, generating an alarm signal when the user suffers an epileptic seizure.	05-14-2009

Patent application number	Description	Published
20080253472	Uart-Encoded Pulse-Modulation Technique - The settings of a UART-based infrared pulse-modulation remote control device are chosen such that the baud rates ensures a reliable communication with the infrared receiver of the controlled appliance.	10-16-2008

Patent application number	Description	Published
20100111967	BISPECIFIC ANTI-VEGF/ANTI-ANG-2 ANTIBODIES - The present invention relates to bispecific antibodies against human VEGF and against human ANG-2, methods for their production, pharmaceutical compositions containing said antibodies, and uses thereof.	05-06-2010
20100159587	ANTIBODIES AGAINST HUMAN ANGIOPOIETIN 2 - The present invention relates to antibodies against human Angiopoietin 2 (anti-ANG-2 antibodies), methods for their production, pharmaceutical compositions containing said antibodies, and uses thereof.	06-24-2010
20100310463	Anti-EpCAM Antibodies - Disclosed are antibodies that bind to Epithelial Cell Adhesion Molecule (EpCAM) and display certain advantages over known antibodies which bind to EpCAM, for example, the antibodies of the invention show good affinity, good cross-reactivity profiles and excellent ADCC and CDCC activity. Antibodies comprising specific heavy and light chain CDRs are disclosed. The invention thus relates to these antibodies and all uses thereof, in particular in the treatment of cancer. The present invention thus provides new antibody-based compositions, methods and combined protocols for treating cancer. Advantageous immunoconjugate compositions and methods using the new anti-EpCAM antibodies are also provided.	12-09-2010